Introduction
============

Organisms respond to stress with enduring changes in metabolism, some of which can be epigenetically transmitted to offspring.[@b1-btt-11-097],[@b2-btt-11-097] It is thought that such persistent changes may involve DNA and histone modification.[@b3-btt-11-097],[@b4-btt-11-097]

Nephrilin is a 40-mer peptide designed as an inhibitor of Rictor complex (also known as mammalian target of rapamycin complex 2, mTORC2). The protective effects of nephrilin have been documented in animal models of metabolic, xenobiotic and traumatic stress.[@b5-btt-11-097]--[@b8-btt-11-097] In previous studies we showed that nephrilin exerts pleiotropic protective effects in a model of severe burn injury, modulating persistent changes in inflammation and sepsis, loss of lean body mass, glycemic control, kidney function and wound healing.[@b7-btt-11-097],[@b8-btt-11-097] The mechanism(s) by which nephrilin peptide exerts its protective effects have not been fully elucidated. Because of the remarkable range of efficacy of nephrilin in many disease models we decided to investigate whether oxidative stress might play a role in the action of nephrilin. We chose to investigate this question in three distinct experimental systems, two in vitro and one in vivo, as individual test systems may exhibit idiosyncrasies.

The pathways by which cells respond epigenetically to stress insult are not well understood. In this work we investigate the hypothesis that nephrilin exerts its pleiotropic protective effects by modulating epigenetic and post-transcriptional changes that conspire to stimulate oxidative stress.

Rho-family GTPases are activated by a variety of extracellular signals. Some well described targets include RhoA (Ras homolog gene family, member A), Cdc42 (cell division control protein 42), and Rac1 (Ras-related C3 botulinum toxin substrate 1). Rac1, an obligate subunit of activated NADPH oxidase, plays a central role in oxidative metabolism in skin and other tissues. Some substrates activated by Rictor complex, such as Prex1/2 and PKC-alpha, may play a role in Rac1 and ERK activation.

Reactive oxygen species (ROS) play an important role in skin cells. UV-A radiation, in particular, is thought to stimulate oxidative damage.[@b9-btt-11-097],[@b10-btt-11-097] Nicotine pre-exposure, especially in combination with hydrogen peroxide, enhances oxidative stress in renal proximal tubule cells, a finding that may be relevant to the clinical observation that smokers experience poorer outcomes in surgery and transplant settings. Activation of the key adaptor protein p66shc has been shown to play a role in this process.[@b16-btt-11-097] p66shc, which is activated by PKC-beta-2 (a substrate of Rictor complex) is known to activate Rac1.[@b12-btt-11-097],[@b13-btt-11-097]

In this work we show the protective effects of nephrilin on UV-A stress in dermal fibroblasts, and on H~2~O~2~--triggered oxidative stress in both dermal fibroblasts and nicotine-pre-exposed renal proximal tubule cells. We further investigate epigenetic and phosphorylation events in kidney tissues derived from a well-established rat scald model in which we previously demonstrated the protective effect of nephrilin on the pleotropic effects of burn injury, including loss of kidney function.[@b8-btt-11-097],[@b14-btt-11-097] In this work we analyze frozen kidney tissue from these earlier studies to show that the action of nephrilin in vivo is consistent with its protective effects in vitro.

Materials and Methods
=====================

Reagents
--------

Nephrilin peptide, a 40-mer peptide carrying a sequence derived from PRR5/Protor (the sequence is conserved in human, rat and mouse species) was synthesized by LifeTein Inc (Hillsborough, NJ, USA) and purified to \>80% purity by HPLC. The design and characterization of nephrilin have been previously described.[@b5-btt-11-097] The sequence of nephrilin peptide and the scrambled control sequence peptide are shown below: Nephrilin: Ac-RGVTEDYLRLETLVQKVVSKGFYKKKQCRPSKGRKRGFCW-amideScrambled: Ac-RDLEGYRVLTETLVQKVVSKGFYKKKQSRPSKGRKRGFSW-amideBCA Protein Kit was from Pierce (Rockford, IL, USA). Antibodies for ELISAs were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) except for antiphospho-p66shc-S36 and anti-collagen-I antibodies (Abcam, Cambridge, MA, USA). CelLytic M cell lysis reagent was obtained from Sigma (St. Louis, MO, USA). Urinary 8-isoprostane ELISA assay kit was from Cayman Chemical (Ann Arbor, MI, USA).

Institutional Review Board Approval
-----------------------------------

All experiments reported in this study received formal approval from the Mayflower Organization for Research & Education Ethics/Institutional Review Board.

Cell Lines and Treatment
------------------------

All assays were done in triplicate. Human HS27 skin fibroblasts were purchased from ATCC (Manassas, VA, USA) and grown at 37°C in DMEM+10% FBS and penicillin/streptomycin to log phase, then seeded in 96-well flat-bottom plates at 8,000 cells/well. After 24 hr incubation cells were treated with 10 uM H~2~O~2~ in PBS for 2 hrs, or UV irradiation as described.[@b15-btt-11-097] After insult, the cells were washed and fresh cell culture medium was added along with 20 ug/ml peptide, or buffer control. Cells were incubated for 5 days in a 37°C humidified 5% CO~2~ incubator, supernatants were harvested for ELISA and cells were tested for viability (sulforhodamine B, SRB assay). The protocol from the supplier (GeneCopoeia, Inc., Rockville, MD, USA) was followed. 50 uL/well of cold fixation solution was added and the cells were incubated at 4 °C for 1 hr. Cells were washed 5 times with distilled water and stained with 50 uL/well SRB stain at RT for 30 min, then washed four times to remove unbound dye. 50 uL solubilization buffer was added per well (5 min, agitation) and the plate was read at 560 nm using a Tecan M200 Plate Reader (Tecan Trading AG, Switzerland). PTECs (NRK52E) were purchased from ATCC and maintained in DMEM supplemented with 10% fetal bovine serum (Life Technologies, Grand Island, NY, USA). Some cells were pre-treated with 200 uM nicotine overnight prior to treatment with either 10 mg/ml nephrilin or scrambled peptide followed by H~2~O~2~.

Determination of intracellular ROS production
---------------------------------------------

For determination of ROS production cells were grown in T25 flasks and pre-treated with 200 uM nicotine as needed. After trypsinization, cells were counted and loaded with the oxidant-sensitive 2′,7′-dichlorofluorescein-diacetate (100 mM, DCFDA; Life Technologies) as described elsewhere.[@b11-btt-11-097] After 30 mins of incubation at 37°C the dye was washed away with fresh HBSS and cells were placed in wells of a 96-well-plate (0.2×10^6^ cell/well) and treated with 400 uM H~2~O~2~. ROS production was determined by recording increase in fluorescence at 485nm~exc~/530nm~em~ in 30-minute-intervals for up to 120 minutes in a plate reader (Fluorocount, Packard). ROS production was calculated as changes in fluorescence/30 minutes/0.2×10^6^ cells and expressed as percentage of the corresponding untreated values.

Kidney tissue
-------------

Frozen rat left kidney tissue and rat urine were gifts from Dr. Celeste Finnerty at UTMB. The experiments from which these tissues were collected have been described in published reports.[@b7-btt-11-097],[@b8-btt-11-097] The rat scald burn model is a modified Walker-Mason model that induces inflammation and hypermetabolism in line with what severely burned patients experience.[@b14-btt-11-097] In the previously reported experiments, scalded animals showed significant reductions in eGFR that were reversed by nephrilin treatment. Group size for animal treatment groups was n=8 for saline-treated burn control (B) group and n=9 for nephrilin-treated burn group (N1, animals treated daily for 1 week post-burn). In addition, a sham control group (S) had four animals.

Cell extracts for ELISAs
------------------------

Preparation of kidney tissue cell extracts for ELISAs was performed as previously described.[@b6-btt-11-097] Specific immunoreactivity was measured by ELISA according to the kit manufacturer's recommendations.

RNA extraction
--------------

30--50 mg of tissue was homogenized in TRIzol^®^ (Invitrogen, Carlsbad CA, USA) and RNA extracted according to the manufacturer's protocol. Linear Acrylamide (AMRESCO, Solon OH, USA) was added as a co-precipitant at a final concentration of 25μg/mL. Concentration and purity of the RNA was determined using the NanoDrop spectrophotometer (Thermo Scientific, Wilmington, DE, USA).

RNA microarray analysis
-----------------------

Total RNA was extracted from approximate 10e7 PTECs cultured either in the presence or absence of H~2~O~2~, or with both Nic+ H~2~O~2~. RNA samples were prepared for microarray analysis following Agilent's one-color microarray-based gene expression analysis Low Input Quick Amp Labeling v6.0. Briefly, an input of 100ng of high quality total RNA (RIN values from 9.8 to 10) was amplified to generate Cyanine-3 labeled cRNA. An amount of 1.65μg of labeled cRNA was hybridized on Agilent Rat Gene Expression Microarrays 4×44K (AMDID 014879). Microarrays were scanned with the Agilent DNA Microarray Scanner at a 3um scan resolution. Data was processed with Agilent Feature Extraction 11.0.1.1 and quantile normalized with Agilent GeneSpring 12.0.

Quantitative PCR
----------------

Quantitative polymerase chain reaction (rt-qPCR) for gene transcripts were performed using RNA extracted from kidney tissue and expressed relative to transcripts of GAPDH, a housekeeping gene. The cDNA synthesis reaction was carried out using 1,000 nanograms of RNA in a final volume of 20 uL following manufacturer's instructions (High --Capacity cDNA Reverse Transcription kit, Applied Biosystems, Foster City, CA, USA). qPCR was carried out with the Fast Real Time 7500 (Applied Biosystems). The final reaction volume was 20 ul and contained: each primer at a final concentration of 200 nM, Power Sybr Green (Applied Biosystems) 1X and 2 ul of template (dilution 1:4 of cDNA synthesis reaction). Samples and standards were run in triplicate. Primer sequences for detecting gene transcripts and control primers for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are proprietary. The thermo cycle conditions were as follows: one cycle at 50°C for 20 sec, one activation cycle at 95°C for 10 minutes, followed by 40 cycles of 15 seconds at 95°C, 45 seconds at 60°C. Melting curve analysis was carried out using the continuous method from the 7500 Software (Applied Biosystems) conducted at 60°C, with increments of 1°C for 15 seconds. Data analysis was carried out with 7500 Software (Applied Biosystems). The auto threshold and baseline options were used for the calculations of Ct values per well. The linear equation for the standard curve (i.e., for preparations containing known quantities of DNA) was then used to interpolate the numbers of copies present in unknown samples.

Statistical analysis
--------------------

Probability values (*p* values) were computed using Student's *t*-test and expressed relative to sham group or saline-treated group.

Results
=======

Effect of nephrilin on UV-treated skin fibroblasts
--------------------------------------------------

UV treatment of skin fibroblasts is known to generate enhanced oxidative stress.[@b9-btt-11-097],[@b10-btt-11-097] Dermal fibroblasts were irradiated with UV-A or treated with H~2~O~2~ and cultured as described in Methods. Cell viability (SRB assay) and collagen-I immunoreactivity in supernatants (ELISA) were measured. As shown in [Figure 1](#f1-btt-11-097){ref-type="fig"}, both UV-A and H~2~O~2~ treatments resulted in significantly reduced cell viability and collagen synthesis in fibroblasts. Co-treatment with 20 ug/ml nephrilin reversed these deficits in all cases. In the non-irradiated control condition too, nephrilin treatment improved cell viability and collagen synthesis in fibroblasts.

Effect of nephrilin on renal PTECs treated with hydrogen peroxide
-----------------------------------------------------------------

Treatment of cultured rat PTECs with H~2~O~2~ has been shown to generate p66shc-mediated ROS and oxidative stress. Pre-treatment with nicotine enhances these effects.[@b16-btt-11-097] We treated PTECs with H~2~O~2~ with or without nicotine pretreatment (Nic) as described in Methods. The results shown in [Figure 2](#f2-btt-11-097){ref-type="fig"} show that H~2~O~2~ treatment significantly enhances cellular ROS in both cases. Co-treatment with 10 ug/ml nephrilin (but not a scrambled peptide control) at the time of H~2~O~2~ addition significantly reverses ROS generation.

RNA microarray analysis of genes induced by oxidative stress in PTECs
---------------------------------------------------------------------

Total RNA was extracted from PTECs cultured either in the presence or absence of H~2~O~2~, or with both Nic+H~2~O~2~. These RNAs were analyzed on Agilent Rat Gene Expression Microarrays 4×44K (AMDID 014879) as described in Methods. Of the 41,105 genes interrogated we identified 49 upregulated (\>3-fold threshhold) genes of known function, for which treatment with H~2~O~2~ alone was \>30% over control, and treatment with the Nic+ H~2~O~2~ combination elevated expression an additional \>30%. These genes are listed in [Table 1](#t1-btt-11-097){ref-type="table"}. Of these, 29% are associated with Wnt and ERK signaling and 21% are associated with GTP-mediated signaling. Ingenuity Pathway software analysis (Palo Alto, CA, USA) using a 3057 gene set in which changes of expression of any magnitude were reported, identified a Rac1/PKC/Prex1 cluster as the network generating a high score (=32) using their proprietary algorithms ([Figure 3](#f3-btt-11-097){ref-type="fig"}). These results, taken together, point to the possible involvement of Prex1, PKCs (both are known to be activated by Rictor complex) in Rac1-mediated effects on oxidative metabolism. Prex1 and (indirectly through p66shc) PKC-beta-2 are both known to activate Rac1.

Analysis of phosphorylation events in kidney tissue from animals treated with nephrilin in vivo
-----------------------------------------------------------------------------------------------

Frozen left kidney tissue slices from burned animals treated with saline or 4mg/kg/day nephrilin were analyzed by ELISA. These animals showed significantly reduced kidney function (eGFR) as a result of injury.[@b8-btt-11-097] The results of the ELISAs are shown in [Figure 4](#f4-btt-11-097){ref-type="fig"}. As suggested by the RNA array analysis, several key signaling molecules involved in the oxidative stress response were dramatically up-regulated by burn injury. These included the key molecules Rac1 and p66shc activated by phosphorylation at Ser71 and Ser36 respectively. In addition, PKC-beta (Ser660) and PKC-alpha (Ser657) were phosphorylated at cognate positions. Total PKC was also elevated. PKC-beta is responsible for activation of p66shc and PKC alpha is a key participant in ERK/Wnt pathway signaling. Nephrilin treatment significantly reversed all of these elevations in phosphorylation but not in total PKC-beta.

Impact of nephrilin treatment on whole body oxidative stress
------------------------------------------------------------

Urine collected from animal donors of kidney tissue was analyzed for 8-isoprostane, a measure of lipid peroxidation. The result is shown in [Figure 5a](#f5-btt-11-097){ref-type="fig"}. A dramatic elevation in 8-isoprostane in burned animals is significantly reversed by treatment with nephrilin.

Expression of PKC-beta, Prex1 and Bik genes in kidney tissue
------------------------------------------------------------

Two of the top five up-regulated genes in the PTEC RNA microarray experiment ([Table 1](#t1-btt-11-097){ref-type="table"}) are known participants in the oxidative stress response: Prex1 is a key GEF for Rac 1/2 --- a subunit of NADPH oxidase --- and Bik is a BH3-only pro-apoptotic molecule induced in oxidative (but not ER-) stress.[@b18-btt-11-097]--[@b21-btt-11-097] As noted above, PKC-beta is a key molecule in the activation of p66shc. We examined the expression of these three genes in whole kidney tissue slices by qPCR ([Figure 5b](#f5-btt-11-097){ref-type="fig"}). The expression of all three genes is dramatically elevated in burn injury. Nephrilin treatment causes minor though significant reductions in Prex1 and Bik expression, but no impact on the level of PKC-beta transcripts. The latter result is consistent with the observed immunoreactivity of total PKC-beta in kidney tissue ([Figure 4](#f4-btt-11-097){ref-type="fig"}).

Global changes in histone 3 phosphorylation and acetylation
-----------------------------------------------------------

In human populations severe burn stress produces a range of enduring dysfunctions that outlive the healing of the external burn wound by months and even years. Phosphorylation of Ser10 in the tail of Histone 3 is a well-documented early response to a variety of stress stimuli.[@b22-btt-11-097] It is believed to be a gating event for more lasting changes in acetylation of this histone, notably at residues Lys9/Lys14.[@b23-btt-11-097] We examined these histone 3 modifications by ELISA of protein extracts from kidney slices ([Figure 5c](#f5-btt-11-097){ref-type="fig"}). In the 24 hours immediately following burn insult, Ser10 phosphorylation is elevated (this elevation having occurred by 6 hours post-burn). Treatment of animals with nephrilin reverses this elevation in H3-Ser10 phosphorylation. At Day 14 post-burn, enduring elevations in acetylation of histone 3 at residues Ly9/Lys14 are observed in saline-treated burned animals but not in the animals treated with nephrilin. This results suggests that enduring changes post-burn could be mediated, at least in part, by global changes in histone acetylation.

Methylation changes in Prex1 promoter region
--------------------------------------------

We examined CpG islands in the region of DNA immediately upstream of the Prex1 gene. We focused on cytosine methylation in a CpG dinucleotide located at −601 (antisense strand) relative to the initiation codon. [Figure 5d](#f5-btt-11-097){ref-type="fig"} shows that methylation at this residue is dramatically reduced in burned animals, consistent with derepression of Prex1 gene expression. This reduction in methylation does not occur in animals treated with nephrilin.

Discussion
==========

In this study we showed that nephrilin peptide specifically reverses the detrimental effects of oxidative stress in (a) cultured fibroblasts (b) cultured PTECs and (c) tissues of rats that had experienced burn injury.

Nephrilin reverses the pronounced elevation of urinary 8-isoprostane in burned animals. Elevation of this marker in human subjects has been linked to increased NADPH oxidase activity in tissues.[@b24-btt-11-097],[@b25-btt-11-097] This result supports our hypothesis that nephrilin works by reversing the effects of oxidative stress.

Deficits in cell viability and collagen I synthesis in fibroblasts caused by UV-A or H~2~O~2~ insult are reversed by 20 ug/ml nephrilin. These insults are believed to increase oxidative stress in these cells and the reversal of their effects by nephrilin supports our hypothesis that nephrilin works by reversing the effects of oxidative stress.[@b9-btt-11-097],[@b10-btt-11-097] Protective effects are even seen in 'unstressed' controls, perhaps indicating the fact that all cultured cells are 'stressed' to some degree.

These results obtained with fibroblast cultures are also intriguing in the context of skin aging, which is believed to be at least partly driven by oxidative stress triggered by sun exposure.[@b10-btt-11-097] The addition of nephrilin peptide to skin via cosmetic formulations is a possible area of future inquiry, though unaided penetration of the skin barrier by peptides is generally poor.

It was previously shown that long-term treatment with NIC exacerbates renal ischemia/reperfusion-dependent oxidative stress in vivo and oxidant (H~2~O~2~)-dependent ROS production in vitro.[@b16-btt-11-097],[@b17-btt-11-097] Here, we show that 10 μg/ml nephrilin peptide but not a control (scrambled sequence) peptide pro-tects PTECs by reducing nicotine-dependent ROS generation. Nephrilin peptide reverses the ROS-generating effects of H~2~O~2~ on renal PTECs with or without pre-exposure to nicotine. This result also supports our hypothesis that nephrilin works by reversing the effects of oxidative stress. Differential analysis of RNA array data from treated PTECs (± H~2~O~2~; ± Nic;) further provided a gene list that supported the possible role of Rac1 and ROS generation.

Using rat kidney tissues previously harvested in a well-characterized burn model we were able to show burn stress-related (a) global elevations in histone-3 phosphorylation (Ser10) and acetylation (Ser9/14); (b) elevation of PKC-beta, Prex1 and Bik gene transcripts; (c) specific methylation decreases in the promoter region of Prex1; and (d) elevated phosphorylation of Rac1-Ser71, PKC-beta-Ser660, total PKC-beta, PKC-alpha-Ser657 and p66shc-Ser36. It is notable that the elevation of Bik was previously shown to correlate with oxidative stress.[@b20-btt-11-097],[@b21-btt-11-097] These results are consistent with and supportive of our main hypothesis.

In all cases except total PKC-beta and PKC-alpha protein and transcripts, treatment of burned animals with nephrilin reversed the effects of burn stress. Taken together with the array data, these results seem to implicate Rac1 activation in nephrilin's mechanism of action via Rictor complex. Additional studies will be needed to prove this point conclusively.

Rictor complex is implicated in the activation of Prex1, PKCs alpha and beta-2 and --- indirectly through PKC-beta-2 --- p66shc.[@b12-btt-11-097],[@b18-btt-11-097],[@b26-btt-11-097],[@b27-btt-11-097] Our results, taken together, suggest at least two pathways (PKC-beta and Prex1) through which Rictor complex might control the activation of Rac1/2, and possibly a third via activated PKC-alpha and ERK.[@b26-btt-11-097] One may further speculate that Rictor (mTORC2) complex acts as a central regulator of oxidative metabolism in mammalian cells in response to stress and may even influence apoptosis through effectors like Bik. The documented pleiotropic protective effects of nephrilin peptide in numerous and diverse rodent models of metabolic, xenobiotic and traumatic stress.[@b5-btt-11-097]--[@b8-btt-11-097] could thus be explained if the Rictor-controlled generation of oxidative stress via Rac1 and NADPH oxidase in these disease models amplifies the disease state (for example, by inducing elevated levels of ROS-triggered inflammation stress or Bik-triggered apoptosis).

Additionally, the effect of nephrilin treatment on the enduring effects of burn stress could be related to stress-triggered changes in epigenetic programs of histone modification and DNA methylation. As we show in this study, nephrilin treatment of animals reverses significant elevations in histone phosphorylation and acetylation as well as CpG methylation changes in the Prex1 promoter region. This observation, combined with our data showing substantial elevations of transcription for PKC-beta and Prex1 as well as total immunoreactive PKCs, and bearing in mind the role of these proteins in Rac1 activation leads us to speculate that perhaps the initial traumatic stress event generates persistent changes via epigenetic programs that affect gene expression levels and protein pools. Interestingly, methylation of Prex1 and PKC genes have previously been shown to affect gene transcription by others.[@b28-btt-11-097],[@b29-btt-11-097] Such transcriptionally-derived changes in 'set point' by increasing the steady state pool of protein could produce exaggerated responses to subsequent stressful stimuli when that pool of protein is post-translationally activated by phosphorylation, thereby setting the stage for a chronic feed-forward state. As Rictor complex regulates the activation of PKC-alpha, PKC-beta, p66shc and Prex1, inactivation of Rictor complex with its designed inhibitor nephrilin would (in theory) allow cells to exit this chronic feed-forward state, despite the presence of elevated PKC and Prex1 substrate pools. This, in turn, might allow a gradual return to the epigenetic baseline initially disrupted by the traumatic stress.

Further studies will be required to show the generality of nephrilin's protective effects on tissues other than kidney. Of particular interest to us is the possible effect of this agent on protecting the CNS, a known target of stress-related damage that can persist for a lifetime e.g. in PTSD and even, possibly, several lifetimes.[@b1-btt-11-097]--[@b3-btt-11-097]
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![Fibroblasts were grown and challenged with either UV-A (~uv~ subscript) or H~2~O~2~ (~ox~ subscript) and cell viability and collagen I synthesis measured as described in Methods. Values are averages of triplicate assays and are expressed relative to control (=100). C=control untreated cells; N=20 ug/ml nephrilin peptide. \*, \*\*: p\<0.05 and p\<0.01 respectively, N versus C pairing; \#, \#\#: p\<0.05 and p\<0.01 respectively, C~uv~ (or C~ox~) versus C pairing.](btt-11-097Fig1){#f1-btt-11-097}

![Renal PTECs were grown and challenged with H~2~O~2~ (~ox~ subscript) ± nicotine (Nic) and ROS generation measured as described in Methods. Values are averages of triplicate assays. C=control untreated cells; N=10 ug/ml nephrilin peptide; S=10 ug/ml scrambled peptide. \*, \*\*: p\<0.05 and p\<0.01 respectively, N (or S) versus C pairing; \# = p\<0.05 C~ox~ versus C.](btt-11-097Fig2){#f2-btt-11-097}

![Pathway analysis using Ingenuity Systems software. Major network (score=32) is shown. Dataset was 3057 genes exhibiting differential expression in the Agilent RNA arrays (see text).](btt-11-097Fig3){#f3-btt-11-097}

![Kidney tissue extracts were prepared and analyzed by ELISA as described in Methods. S=sham group; B=burn+saline; N1=burn+4mg/kg/day SQ nephrilin for 1 week post-burn. \*\*p\<0.01, N1 versus B; \#, \#\#: p\<0.05 and p\<0.01, B versus S.\
**Abbreviation:** AU, arbitrary units.](btt-11-097Fig4){#f4-btt-11-097}

![All extracts were prepared and assays performed as described in Methods**. (A)** Urine samples were assayed by ELISA and standardized against Cystatin C. **(B)** Gene transcripts were standardized versus GAPDH as standard. **(C)** Histone-3 phosphorylation and acetylation, as well as total histone-3, were determined by ELISA. Kidney tissues from 6 (B6=B group 6 hr) and 24 hours (S24, B24, N24) post-burn were assayed for phosphorylation, as early event. **(D)** CpG methylation is expressed in arbitrary units; each bar is an average of 4 animals. S=sham group; B=burn+saline; N1=burn+4mg/kg/day SQ nephrilin for 1 week post-burn. \*p\<0.05, N1 versus B; \# p\<0.05, B versus S.](btt-11-097Fig5){#f5-btt-11-097}

###### 

RNA arrays. RNAs were extracted from cells and analyzed on Agilent Rat Gene Expression Microarrays 4×44K (AMDID 014879) as described in Methods. Of 41,105 genes interrogated 49 upregulated (\>3-fold threshhold) genes of known function for which treatment with H~2~O~2~ alone was \>30% over control and treatment with the Nic+ H~2~O~2~ combination elevated expression an additional \>30% were identified.

  ProbeName       GeneSymbol   GenbankAccession   GeneName                                                                   FOLD UPREG
  --------------- ------------ ------------------ -------------------------------------------------------------------------- ------------
  A_44_P812665    Mypn         NM_001107628       myopalladin                                                                9.3
  A_42_P812805    Smoc2        NM_001106215       SPARC related modular calcium binding 2                                    8.4
  A_44_P704258    En2          NM_001109214       engrailed homeobox 2                                                       8.2
  A_43_P12905     Bik          NM_053704          BCL2-interacting killer (apoptosis-inducing)                               8.2
  A_44_P288548    Prex1        NM_001135718       phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1   8.0
  A_44_P285988    Chrdl2       NM_001107537       chordin-like 2                                                             7.6
  A_44_P361951    Adssl1       XM_001072867       adenylosuccinate synthase like 1                                           7.2
  A_44_P356161    Ppy          NM_012626          Pancreatic Polypeptide                                                     7.1
  A_43_P15474     Spef2        NM_022620          sperm flagellar 2                                                          6.9
  A_44_P572533    Cabyr        NM_001143893       calcium binding tyrosine-(Y)-phosphorylation regulated                     5.8
  A_44_P323349    Gria4        NM_017263          glutamate receptor, ionotropic, AMPA 4                                     5.7
  A_42_P832832    Ckm          NM_012530          creatine kinase, muscle                                                    5.6
  A_44_P250467    Cd22         NM_001107503       CD22 molecule                                                              5.2
  A_42_P536266    Dnm3         XM_006250137       dynamin 3                                                                  5.2
  A_44_P258225    Ly6h         NM_001134839       lymphocyte antigen 6 complex, locus H                                      5.2
  A_44_P414340    Amelx        NM_019154          amelogenin, X-linked                                                       5.0
  A_44_P208532    ldo2         XM_006222273       indoleamine 2,3-dioxygenase 2                                              4.9
  A_44_P145562    Dock2        XM_001068649       dedicator of cytokinesis 2                                                 4.7
  A_43_P13056     IllOra       NM_057193          interleukin 10 receptor, alpha                                             4.7
  A_44_P665425    Rnfl65       NM_001164505       ring finger protein 165                                                    4.5
  A_44_P762053    Palld        XM_006253064       palladin, cytoskeletal associated Protein                                  4.4
  A_44_P104630    Lat2         NM_173840          linker for activation of T cells family, member2                           4.4
  A_44_P236523    Hoxdl0       NM_001107094       homeo box D10                                                              4.4
  A_44_P212521    Gzmf         NM_153466          granzyme F                                                                 4.3
  A_44_P497282    Rab11fip4    NM_001107023       RAB11 family interacting protein 4 (class II)                              4.3
  A_44_P416899    Npy4r        NM_031581          neuropeptide V receptor V4                                                 4.3
  A_44_P1043302   Crb3         NM_001025661       crumbs homolog 3 (Drosophila)                                              4.3
  A_44_P1036769   Matn1        NM_001006979       matrilin 1, cartilage matrix Protein                                       4.2
  A_42_P841193    Ddit4l       NM_080399          DNA-damage-inducible transcript 4-like                                     4.2
  A_44_P291071    Rora         NM_001106834       RAR-related orphan receptor A                                              4.2
  A_43_P18101     Eif3         NM_001024768       E74-like factor 3                                                          4.1
  A_42_P525876    Erg          NM_133397          v-ets avian erythroblastosis virus E26 oncogene                            4.0
  A_44_P372305    Syn3         NM_017109          synapsin 111                                                               3.9
  A_43_P19535     Mrgprb4      NM_001002287       MAS-related GPR, member B4                                                 3.9
  A_44_P520521    Slcl7a2      NM_001107353       solute carrier family 17, member 2                                         3.8
  A_44_P1001317   Nabp1        NM_001014216       nucleic acid binding protein 1                                             3.8
  A_44_P555417    Hoga1        NM_001106355       4-hydroxy-2-oxoglutarate aldolase 1                                        3.7
  A_44_P147156    Rbm47        NM_001005882       RNA binding motif protein 47                                               3.7
  A_44_P199028    Dkk1         NM_001106350       dickkopf WNT signaling Pathway inhibitor 1                                 3.5
  A_44_P144788    Mtmr12       XM_006232046       myotubularin related protein 12                                            3.5
  A_43_P18793     Gfpt2        NM_001002819       glutamine-fructose-6-phosphate transaminase 2                              3.4
  A_44_P485948    Cux2         NM_001271380       cut-like homeobox 2                                                        3.3
  A_44_P491864    Fgfl4        XM_006252526       fibroblast growth factor 14                                                3.1
  A_44_P1020482   Nalcn        NM_153630          sodium leak channel, non-selective                                         3.0
  A_42_P601961    Susd3        NM_001107341       sushi domain containing 3                                                  3.0
  A_44_P318628    Chrnb2       NM_019297          cholinergic receptor, nicotinic, beta 2 (neuronal)                         3.0
  A_44_P1035007   Chrne        NM_017194          cholinergic receptor, nicotinic, epsilon (muscle)                          3.0
  A_44_P178498    B3galt5      NM_001105887       UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, Polypeptide 5           3.0
  A_44_P1048543   Ghrh         NM_031577          growth hormone releasing hormone                                           3.0
